{
  "ptid_time": "068_S_2316_2011-03-10",
  "img_path": "/data/qiuhui/data/adni/images/068_S_2316/2011-03-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 29,724 mm³, 5.9% above the reference mean. With a Z-score of 0.14 (55.4th percentile), this represents normal volume ; hippocampal volume measures 6,693 mm³, 5.9% below the reference mean. With a Z-score of -0.54 (29.3th percentile), this represents normal volume ; whole brain volume measures 1,064,570 mm³, 9.2% above the reference mean. With a Z-score of 1.16 (87.7th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,196 mm³, 13.0% below the reference mean. With a Z-score of -0.80 (21.3th percentile), this represents normal volume ; fusiform gyrus volume measures 18,217 mm³, 7.1% above the reference mean. With a Z-score of 0.64 (74.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,351 mm³, 9.5% below the reference mean. With a Z-score of -0.82 (20.5th percentile), this represents normal volume . ",
  "text_data": "Age is 74.3 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Major Surgical Procedures. MMSE: 28.0. MoCA: 18.0. Logical Memory: 8.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.48 SUVR (profound elevated); Amyloid beta: 589.60 pg/mL (mild reduced); Total tau: 634.00 pg/mL (profound elevated); Phosphorylated tau: 69.57 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows normal to mildly reduced volumes in most brain regions, with the entorhinal cortex and middle temporal gyrus slightly below average but still within normal range. However, the MoCA score of 18 (below the typical cutoff of 26 for normal cognition) and profound elevations in T-tau, P-tau, and AV45 (indicating amyloid pathology) strongly suggest neurodegenerative disease. The MMSE of 28 is less sensitive but does not rule out early cognitive impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key findings: Biomarkers strongly support AD pathology, MoCA indicates significant cognitive impairment, and structural changes, while not severe, align with early neurodegeneration.)*",
  "timestamp": "2025-07-26T08:57:42.837112"
}